Vermillion Wealth Management, Inc. Rockwell Medical, Inc. Transaction History
Vermillion Wealth Management, Inc.
- $370 Billion
- Q3 2025
A detailed history of Vermillion Wealth Management, Inc. transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Vermillion Wealth Management, Inc. holds 360 shares of RMTI stock, worth $334. This represents 0.0% of its overall portfolio holdings.
Number of Shares
360
Previous 360
-0.0%
Holding current value
$334
Previous $305,000
41.64%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RMTI
# of Institutions
41Shares Held
3.4MCall Options Held
25.6KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA1.35MShares$1.26 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny562KShares$522,8500.0% of portfolio
-
Geode Capital Management, LLC Boston, MA323KShares$300,5270.0% of portfolio
-
Black Rock Inc. New York, NY219KShares$203,4100.0% of portfolio
-
Gsa Capital Partners LLP London, X0164KShares$152,4990.02% of portfolio
About ROCKWELL MEDICAL, INC.
- Ticker RMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 10,675,200
- Market Cap $9.93M
- Description
- Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...